Dexamethasone Sodium Phosphate
CAS number： 2392-39-2
Molecular formula： C22H28FNa2O8P
molecular weight： 516.405
Chemical structure：
Producers shown on SFDA
(Record date:21/10/2021）
Producer | Documents | GMP Valid till(based on SFDA) |
Henan Huijin Pharmaceutical Co., Ltd. | GMP | Valid till July 2025 |
Jiangxi Xinganjiang Pharmaceutical Co., Ltd. | GMP | Valid till September 2024 |
Hunan Chengda Biotechnology Co., Ltd. | GMP | Valid till February 2024 |
Tianjin Tianyao Pharmaceutical Co., Ltd. | GMP | Valid till December 2022 |
Zhejiang Xianju Junye Pharmaceutical Co., Ltd. | GMP | Valid till February 2022 |
Producers shown on EP
(Quoted from EP website；record date:21/10/2021）
| Substance | Certificate Holder | Certificate Number | Issue Date | Status | End date | Type |
| Dexamethasone sodium phosphate | SYMBIOTICA SPECIALITY INGREDIENTS SDN. BHD. Perai MY | R1-CEP 2006-184 - Rev 00 | 03/10/2013 | Valid | / | Chemical |
| Dexamethasone sodium phosphate | SANOFI CHIMIE Gentilly FR | R2-CEP 1992-014 - Rev 06 | 19/07/2016 | Valid | / | Chemical |
| Dexamethasone sodium phosphate | TIANJIN TIANYAO PHARMACEUTICALS CO., LTD. Tianjin CN | R1-CEP 2013-142 - Rev 00 | 15/05/2020 | Valid | / | Chemical |
| Dexamethasone sodium phosphate | PHARMACIA & UPJOHN COMPANY LLC Kalamazoo US | R1-CEP 1998-154 - Rev 06 | 07/07/2021 | Valid | / | Chemical |
| Dexamethasone sodium phosphate | CURIA SPAIN S.A.U. Boecillo ES | R1-CEP 2008-026 - Rev 01 | 24/08/2021 | Valid | / | Chemical |
Producer:Henan Huijin Pharmaceutical Co., Ltd., established in 2013, covers an area of 200 mu with a total investment of 100 million yuan. The company has an engineering technology research center and more than a dozen API synthesis workshops with an annual production capacity of 1000 tons. The company has passed ISO9001, ISO14001, OHSAS18001, "cleaner production" and other certifications.
Staff size:/
Registered capital:RMB 10 million
It has successively developed and put into production a number of varieties, including dizhongqianggu capsule, a national exclusive variety, compound yinqiaoammomin capsule, and other capsules, tablets, granules, powders, lozenges, APIs and other dosage forms. All products of the company have passed GMP certification, and the annual production capacity is 5000 tons of APIs, 2 billion tablets and 800 million capsules, 100 million bags of granules.
Registered capital:RMB 49 million 800 thousand
Producer:Hunan Chengda Biotechnology Co., Ltd., established in 2002, covers an area of 186 mu, with a total construction area of 72000 square meters and fixed assets of 250 million yuan. It is a high-tech enterprise mainly engaged in steroidal hormone drug raw materials, intermediates and veterinary drugs. According to GMP requirements and advanced EHS management concept, the company has basically formed R & D process, synthetic production The whole industry chain of quality control management is closed-loop, and has obtained GMP certification. Staff size:100-199 people Registered capital: RMB 50 million Staff size:About 3000 people Registered capital:RMB 1 billion 101 million Staff size:600-699 people Registered capital:USD 15.43 million For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978
Producer:Tianjin Tianyao Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Tianjin Jinyao Group Co., Ltd., is the first API production unit in Tianjin that has all passed the national GMP certification. It is the largest scientific research, production and export base of steroid corticosteroids in Asia. The company mainly produces more than 40 varieties of corticosteroid raw materials, cardiovascular and cerebrovascular raw materials, analgesic raw materials and preparation drugs, of which many products have passed the certification of FDA and European Pharmacopoeia Committee, and become a qualified supplier of Pfizer and other large multinational companies. The company's leading product dexamethasone (corticosteroid drugs) series technology and product quality have reached the international advanced level. Taking advantage of low cost and service advantages, the company has occupied the Asian market of dexamethasone and opened the European and American markets; The company's annual production capacity of corticosteroid APIs has reached more than 200 tons.
Producer:Zhejiang Xianju Junye Pharmaceutical Co., Ltd. was founded in 1998, At present, the company has three production bases in Xianju and Jiangxi Wannian, and has branches in Hangzhou, Shanghai, the United States and Italy, realizing the integrated production and R & D system at home and abroad. The products mainly cover progesterone, sex hormone, cortical hormone, etc. it is one of the major manufacturers of hormone raw materials and intermediate systems in the world.
Tel: Cell/WhatsApp/WeChat: +86 18402846978
Email: paulzhang@yinuopharmchem.com
SKYPE